Evidence map›Paper›PMID 40355429›Full record

ArticleNature communications2025

SARS-CoV-2 ORF3a drives dynamic dense body formation for optimal viral infectivity.

Stella Hartmann, Lisa Radochonski, Chengjin Ye, Luis Martinez-Sobrido, Jueqi Chen

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Stella HartmannDepartment of Microbiology, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-4777-2780
Lisa RadochonskiDepartment of Microbiology, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0009-0008-4241-7054
Chengjin YeTexas Biomedical Research Institute, San Antonio, TX, USA.ORCID http://orcid.org/0000-0002-1934-9494
Luis Martinez-SobridoTexas Biomedical Research Institute, San Antonio, TX, USA.ORCID http://orcid.org/0000-0001-7084-0804
Jueqi ChenDepartment of Microbiology, University of Chicago, Chicago, IL, USA. jueqi@uchicago.edu.ORCID http://orcid.org/0000-0001-7164-8988

Funding

Facility Management, Maintenance and Operations CoreUC7AI180312 · NIAID · UNIVERSITY OF CHICAGO · PI Dominique Missiakas · 2023 to 2026
$12.4M
Trans-Golgi Network Remodeling by Microbial FactorsR35GM151390 · NIGMS · UNIVERSITY OF CHICAGO · PI Jueqi Chen · 2023 to 2026
$1.8M
NIAID NIH HHS UC7 AI180312NIGMS NIH HHS R35 GM151390U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM151390
6 · The paper itself

Abstract

SARS-CoV-2 hijacks multiple organelles for virion assembly, of which the mechanisms have not been fully understood. Here, we identified a SARS-CoV-2-driven membrane structure named the 3a dense body (3DB). 3DBs are unusual electron-dense and dynamic structures driven by the accessory protein ORF3a via remodeling a specific subset of the trans-Golgi network (TGN) and early endosomal membrane. 3DB formation is conserved in related bat and pangolin coronaviruses but was lost during the evolution to SARS-CoV. During SARS-CoV-2 infection, 3DB recruits the viral structural proteins spike (S) and membrane (M) and undergoes dynamic fusion/fission to maintain the optimal unprocessed-to-processed ratio of S on assembled virions. Disruption of 3DB formation resulted in virions assembled with an abnormal S processing rate, leading to a dramatic reduction in viral entry efficiency. Our study uncovers the crucial role of 3DB in maintaining maximal SARS-CoV-2 infectivity and highlights its potential as a target for COVID-19 prophylactics and therapeutics.

Indexed as

COVID-19SARS-CoV-2Viroporin ProteinsAnimalsChlorocebus aethiopsEndosomesHEK293 CellsHumansSpike Glycoprotein, Coronavirustrans-Golgi NetworkVero CellsVirionVirus AssemblyVirus InternalizationORF3a protein, SARS-CoV-2Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Viroporin Proteins

Identifiers

PMID40355429
PMCPMC12069715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.